Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Gwenael Le Teuff"'
Autor:
Stephanie Puget, Cathy Philippe, Dorine A Bax, Bastien Job, Pascale Varlet, Marie-Pierre Junier, Felipe Andreiuolo, Dina Carvalho, Ricardo Reis, Lea Guerrini-Rousseau, Thomas Roujeau, Philippe Dessen, Catherine Richon, Vladimir Lazar, Gwenael Le Teuff, Christian Sainte-Rose, Birgit Geoerger, Gilles Vassal, Chris Jones, Jacques Grill
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e30313 (2012)
Diffuse intrinsic pontine glioma (DIPG) is one of the most frequent malignant pediatric brain tumor and its prognosis is universaly fatal. No significant improvement has been made in last thirty years over the standard treatment with radiotherapy. To
Externí odkaz:
https://doaj.org/article/6e75a25c66ea440bbeecf2bc0985720c
Autor:
Susanne A. Gatz, Pablo Berlanga, Baptiste Archambaud, Yassine Bouchoucha, Nicolas André, Nadege Corradini, Windy Rondof, Jonathan Rubino, Souad Nebchi, Antonin Marchais, Estelle Thebaud, Alba Rubio San Simón, Natasha K. van Eijkelenburg, Lynley V. Marshall, Anne-Sophie Defachelles, Adela Canyete, Stephane Ducassou, Guy Makin, Michela Casanova, Emilie De Carli, Arnaud Petit, Gwenael Le Teuff, Xavier Paoletti, Peter G. Mortimer, Gilles Vassal, Birgit Geoerger
Publikováno v:
Cancer Research. 83:CT088-CT088
Background: AcSé-ESMART is a proof-of-concept, phase I/II, platform trial, designed to explore targeted agents in a molecularly enriched relapsed/refractory pediatric population. Arm D was evaluating the PARP inhibitor (PARPi) olaparib (ola) in comb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d245cfaa2808a255360e59d3d3e2e342
https://doi.org/10.1158/1538-7445.am2023-ct088
https://doi.org/10.1158/1538-7445.am2023-ct088
Autor:
Nathalie Lassau, Yohann Loriot, Karim Fizazi, A. Guida, Bernard Escudier, Laurence Albiges, Margarida Matias, Giulia Bacciarelo, Christophe Massard, Gwenael Le Teuff, Caroline Brard
Publikováno v:
European journal of cancer (Oxford, England : 1990). 79
Background Axitinib has shown activity in metastatic renal cell carcinoma (mRCC) in a large phase III clinical trial and was approved in patients who failed first-line therapy. This drug has been available in France since November 2012. The objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aa21f365a2f61436ec35d31e2898d5b
https://pubmed.ncbi.nlm.nih.gov/28511146
https://pubmed.ncbi.nlm.nih.gov/28511146
Publikováno v:
BMC Bioinformatics, Vol 24, Iss 1, Pp 1-23 (2023)
Abstract Background The research of biomarker-treatment interactions is commonly investigated in randomized clinical trials (RCT) for improving medicine precision. The hierarchical interaction constraint states that an interaction should only be in a
Externí odkaz:
https://doaj.org/article/6d55fabc0d1942cc8579637748337697
Autor:
Emeline Colomba, Carolina Alves Costa Silva, Gwénaël Le Teuff, Jamie Elmawieh, Daniel Afonso, Axelle Benchimol‐Zouari, Annalisa Guida, Lisa Derosa, Ronan Flippot, Bruno Raynard, Bernard Escudier, François Bidault, Laurence Albiges
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 5, Pp 2405-2416 (2022)
Abstract Background Cabozantinib, a standard of care metastatic renal cell carcinoma (mRCC), may be associated with weight and muscle loss. These effects of new generation VEGFR tyrosine kinase inhibitor on muscle mass loss are poorly described. Meth
Externí odkaz:
https://doaj.org/article/9c6e69245d384a6088532908f44f179b
Autor:
Dominique, Valteau-Couanet, Marie-Cécile, Le Deley, Christophe, Bergeron, Stéphane, Ducassou, Jean, Michon, Hervé, Rubie, Gwenael, Le Teuff, Carole, Coze, Dominique, Plantaz, Nicolas, Sirvent, Jeanine, Bouzy, Pascal, Chastagner, Olivier, Hartmann
Publikováno v:
Pediatric bloodcancer. 61(6)
To evaluate long-term survival of the first cohort of stage-4 neuroblastoma patients treated with the N7 induction chemotherapy, surgery of the primary tumor and high-dose chemotherapy (HDC) containing Busulfan-Melphalan (Bu-Mel) followed by autologo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d6cd407ac45f158a8073f172abb4be50
https://pubmed.ncbi.nlm.nih.gov/24535945
https://pubmed.ncbi.nlm.nih.gov/24535945
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lisa Derosa, Karim Fizazi, Mohamed Amine Bayar, Christophe Massard, Gwenael Le Teuff, Laurence Albiges, Bernard Escudier, Yohann Loriot
Publikováno v:
Journal of Clinical Oncology. 34:e16113-e16113
e16113Background: Current prognostic models for second-line TT in mRCC, from Memorial Sloan-Kettering Cancer Center (MSKCC) and International Metastatic Renal Cell Carcinoma Database Consortium (IM...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b37026b20b709cfe9307745d7a6dddf
https://doi.org/10.1200/jco.2016.34.15_suppl.e16113
https://doi.org/10.1200/jco.2016.34.15_suppl.e16113
Autor:
UK Childrens Cancer, Marie-Cécile Le Deley, Nathalie Gaspar, Gwenael Le Teuff, Valérie Laurence, Heribert Juergens, Jeremy Whelan, Odile Oberlin, Keith Wheatley, Andreas Ranft, Douglas S. Hawkins, Ian Judson, Gesellschaft fur Padiatrische Onkologie und Hamatologie, Sandrine Marreaud, Gsf, Hendrik van den Berg, Ruth Ladenstein, Perrine Marec-Berard, Bruce Morland, Susanne Amler, Jarmila Kruseova, Uta Dirksen, Bernadette Brennan
Publikováno v:
Journal of Clinical Oncology. 34:11000-11000
11000Background: EE99R2Loc (ISRCTN61438620) was conducted in 12 countries, by 4 cooperative groups: GPOH, SFCE/GSF, UK-CCLG, and EORTC. It evaluated effects on event-free (EFS, main endpoint) and o...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95aabdb09257b14efe24e577eb216326
https://doi.org/10.1200/jco.2016.34.15_suppl.11000
https://doi.org/10.1200/jco.2016.34.15_suppl.11000
Autor:
Bernadette Brennan, Ian Judson, Mark L. Bernstein, Richard Gorlick, Mark Krailo, Herbert Juergens, Lars Hjorth, Nathalie Cozic, Jeremy Whelan, Michael Paulussen, Keith Wheatley, Perrine Marec-Berard, Marie-Cécile Le Deley, Nathalie Gaspar, Uta Dirksen, Gwenael Le Teuff, Douglas S. Hawkins, Neyssa Marina, Andreas Faldum, Richard B. Womer
Publikováno v:
Journal of Clinical Oncology. 34:11001-11001
11001Background: EE99R2pul (ISRCTN61438620) was conducted in 16 countries, by 5 cooperative groups: COG, SFCE/GSF, GPOH, UK CCLG, EORTC. It evaluated the effect on event-free (EFS, main endpoint) a...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9857f3bcaac607e40bf1e9565acd069
https://doi.org/10.1200/jco.2016.34.15_suppl.11001
https://doi.org/10.1200/jco.2016.34.15_suppl.11001